As of 2025-10-19, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (20.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -444.1%.
The range of the Relative Valuation is (16.70) - (21.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 22.2x | 19.0x |
| Forward P/E multiples | 17.4x - 28.6x | 23.0x |
| Fair Price | (16.70) - (21.33) | (20.20) |
| Upside | -384.5% - -463.4% | -444.1% |
| Date | P/E |